Related Experiment Video
Updated: Mar 18, 2026

10:19
Substernal Thyroid Biopsy Using Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
Published on: November 10, 2014
26.5K
[Radiofrequency ablation of a symptomatic benign thyroid nodule]
T M van Ginhoven1, E T Massolt, D C Bijdevaate
1Erasmus MC, Rotterdam.
Nederlands Tijdschrift Voor Geneeskunde
|June 30, 2016
Summary
Radiofrequency ablation (RFA) offers a new, effective treatment for benign thyroid nodules in the Netherlands, significantly reducing nodule size and associated symptoms without surgery.
Area of Science:
- Endocrinology
- Minimally Invasive Procedures
- Oncology
Background:
- Benign thyroid nodules can cause cosmetic issues and mass effect symptoms.
- Traditional treatments like surgery or radioactive iodine carry risks and side effects.
- Radiofrequency ablation (RFA) presents a novel, heat-based tissue ablation technique.
Purpose of the Study:
- To introduce and evaluate Radiofrequency Ablation (RFA) for benign thyroid nodules in the Netherlands.
- To assess the effectiveness of RFA in reducing nodule volume and alleviating symptoms.
- To monitor initial outcomes, including risks and patient satisfaction, before widespread adoption.
Main Methods:
- Radiofrequency ablation (RFA) was employed to treat patients with benign thyroid nodules.
- The technique utilizes heat to selectively ablate nodular tissue.
- Patient outcomes, including nodule size reduction and symptom relief, were monitored.
Main Results:
- RFA achieved an average nodule size reduction of 80% within the first year.
- Significant decrease in both symptomatic and cosmetic complaints was observed.
- The procedure offers an alternative to surgery or radioactive iodine treatment.
Conclusions:
- Radiofrequency ablation (RFA) is an effective minimally invasive treatment for benign thyroid nodules.
- The technique provides substantial symptom relief and cosmetic improvement.
- Further monitoring of effectiveness, risks, and patient satisfaction is recommended before RFA becomes standard care in the Netherlands.

